/Companies

Tempus

NASDAQ: TEMUnicorn · $5.9B

Chicago, US · Founded 2015 · 11 known investors

Find your way into Tempus

Sign up to see every warm intro you have to Tempus

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tempus team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Tempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas. The company operates a technology platform that connects healthcare institutions to aggregate and analyze multimodal patient data, serving physicians, pharmaceutical companies, and healthcare systems seeking to optimize therapy selection and drug development.

Founders & leadership

Tempus was founded in 2015 by Eric Lefkofsky.

ELEric Lefkofsky
Eric LefkofskyFounderEntrepreneur & Philanthropist
EP
Erik PhelpsExecutive
RFRyan Fukushima
Ryan FukushimaExecutiveRyan Fukushima joined Tempus Labs as its first employee and held leadership roles through the company's IPO, including leading the Data & Apps division. He is cofounder and former CEO of Pathos AI, an AI-focused drug development company focused on identifying patient subgroups for oncology therapeutics.

Board

BK
Brad KeywellBoard director
PBPeter Barris
Peter BarrisBoard directorChairman Emeritus of New Enterprise Associates at NewView Capital

Investors · 11

Reported raises · per SEC filings

Form D private placements

$271M disclosed across 4 of 5 rounds · 2017–2022

▶$10MraisedOct 2022 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • ROBERT GHENCHEVDirector
  • JENNIFER DOUDNADirector
  • WAYNE FREDERICKDirector
  • PETER BARRISDirector
  • SCOTT GOTTLIEBDirector
  • ERIK PHELPSExecutive Officer
  • TED LEONSISDirector
  • ERIC BELCHERDirector
  • NADJA WESTDirector
  • JIM ROGERSExecutive Officer
  • ERIC LEFKOFSKYExecutive Officer, Director
  • RYAN FUKUSHIMAExecutive Officer
Offering amount
$10M
Amount sold
$10M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$111MraisedSep 2018 · 16 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric LefkofskyExecutive Officer, Director
  • Ryan FukushimaExecutive Officer
  • Peter BarrisDirector
  • Brad KeywellDirector
  • Erik PhelpsExecutive Officer
Offering amount
$111M
Amount sold
$111M
Sales commissions
$2.2M
Placement agents
Allen & Company LLC
First sale
Aug 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$80MraisedMar 2018 · 16 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Erik PhelpsExecutive Officer
  • Peter BarrisDirector
  • Ryan FukushimaExecutive Officer
  • Brad KeywellDirector
  • Eric LefkofskyExecutive Officer, Director
Offering amount
$100M
Amount sold
$80M
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$70MraisedSep 2017 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Brad KeywellDirector
  • Peter BarrisDirector
  • Erik PhelpsExecutive Officer
  • Eric LefkofskyExecutive Officer, Director
  • Ryan FukushimaExecutive Officer
Offering amount
$70M
Amount sold
$70M
First sale
Sep 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$5.9Bvaluation at IPOJun 2024 · $37.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

2 people who came through Tempus went on to found or lead other companies.

Frequently asked questions

What does Tempus do?
Tempus AI develops artificial intelligence-powered diagnostic tests that integrate genomic, clinical, and imaging data to guide personalized treatment decisions in oncology and other disease areas. The company operates a technology platform that connects healthcare institutions to aggregate and analyze multimodal patient data, serving physicians, pharmaceutical companies, and healthcare systems seeking to optimize therapy selection and drug development.
Who founded Tempus?
Tempus was founded by Eric Lefkofsky in 2015.
Who are Tempus's investors?
Tempus's investors include Caesar Ventures, Compound, FPV, Khosla Ventures, Lightbank, Lingotto, New Enterprise Associates (NEA), Revolution and 3 more.
How much funding has Tempus raised?
Tempus has disclosed $271M raised across 4 of its 5 known rounds.
Where is Tempus headquartered?
Tempus is headquartered in Chicago, US.